Peginterferon alfa-2b - Enzon/Merck & Co.
At a glance
- Drug Originator Enzon Pharmaceuticals
- Drug Licenced by Merck & Co
- Drug Class Antihaemorrhagics; Antineoplastics; Antiretrovirals; Antivirals; Immunotherapies; Interferons; Polyethylene glycols; Skin disorder therapies
- Mechanism of Action Interferon alpha replacements
- USA Patent Applicants SCHERING
- USA Patents 41
- BLAs 1
- International Patents 977
Disclaimer